Skip to main content

Viamet Gets Fast Track Status for Valley Fever Therapy

Durham-based Viamet Pharmaceuticals has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its anti-fungal agent VT-1598, a novel oral therapy for the treatment of valley fever.

Bullish on Ag Tech, Alexandria Creating R&D ‘Mega Campus’ in RTP

Already a major landlord in the Research Triangle Park, California-based Alexandria Real Estate Equities is developing a unique multi-tenant research and development campus in the Research Triangle Park to drive North Carolina’s global leadership in agricultural biotechnology.

Liver Cell Therapy Developed in Durham Accepted for Canadian Review

A cell-based therapy developed in Durham for a rare liver disease in newborns has been accepted for regulatory review in Canada.

Innovate Biopharmaceuticals Using Reverse Merger to Go Public

Raleigh-based Innovate Biopharmaceuticals may become a publicly traded company soon following an agreement to merge with a California company already listed on the NASDAQ stock exchange.

Panaceutics Partners with Florida Hospital to Boost Medicine Adherence

Panaceutics, a personalized medicine and clinical nutrition company in Research Triangle Park, will partner with Florida Hospital’s Cardiovascular Institute on a new way to help patients with heart disease take all of their medicines as prescribed.

Panaceutics, a personalized medicine and clinical nutrition company in Research Triangle Park, will partner with Florida Hospital’s Cardiovascular Institute (CVI) on a new way to help patients with heart disease take all of their medicines as prescribed.

'Shop Class' Goes High Tech At New RTP Prototyping Lab

First Flight Venture Center has set a date of September 13, 2017 to roll back the doors of Hangar6, calling it “an advanced rapid prototyping facility.”

Is Science Comedian an Oxymoron? No, it's Tim Lee, Ph.D., and He's Definitely No Moron!

A sow and a soybean walk into a lab.

It might be the start of a good joke. I don’t know. But Tim Xtreme Lee has done the due diligence to extract the funny from the corn.  

World-Leading Seqirus Flu Vax Factory in NC Makes History -- Again

The billion-dollar cell culture Seqirus vaccine factory in Holly Springs has hit yet another milestone. The highly skilled workers at the sprawling factory southeast of Raleigh successfully produced the world’s first cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.

Innocrin Granted SME Status by European Medicines Agency

Durham-based Innocrin Pharmaceuticals, a clinical-stage company focused on developing new cancer treatments, has received a regulatory boost for its work in Europe.

CiVentiChem Gets First FDA Nod on Commercial API from Cary HQ

CiVentiChem has received its first U.S. Food and Drug Administration approval for a generic commercial active pharmaceutical ingredient (API) manufactured at its Cary headquarters.

Pages

Subscribe to RSS - Triangle